Abstract
AMI (acute mesenteric ischemia) is basically a serious vascular emergency which requires urgent analysis and intervention to sufficiently reinstate mesenteric blood flow and to cure bowel necrosis and death of the patient. The primary cause is diverse, and the prognosis depends upon the precise pathological findings. Besides the procedure in understanding the AMI (acute mesenteric ischemia) pathogenesis and the modern treatment modalities development, AMI remains a specific and diagnostic challenge for medical professionals and clinicians, and the diagnosis delay contributes to the persistence high rate of mortality. Initial analysis and prompt operative treatment both are essential to enhance the clinical outcomes.
In a broader view, AMI (acute mesenteric ischemia) may be categorized further as venous or arterial. As an arterial disease, it sub-divided into NOMI (non-occlusive mesenteric ischemia) and OMAI (occlusive mesenteric arterial ischemia; where OMAI further divided in AMAE (Acute Mesenteric Arterial Embolism) and AMAT (Acute Mesenteric Arterial Thrombosis). On the contrary, acute mesenteric ischemia as the venous disease can be MVT (mesenteric venous thrombosis).